Runfeng Li
Impact in
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds
- Plant-based Medicinal Research
-
- Andrographolide Research and Applications
Papers in ⓘ
- Epidemiology 17
- Influenza Virus Research Studies 16
- Respiratory viral infections research 7
- Immunology 13
- Immune Response and Inflammation 6
- interferon and immune responses 6
- Co-authors
- Zifeng Yang (29 shared papers)Haiming Jiang (16 shared papers)Jin Zhao (9 shared papers)Weiqi Pan (4 shared papers)Qinhai Ma (4 shared papers)Chufang Li (3 shared papers)Yongxia Shi (4 shared papers)Kui Zheng (3 shared papers)
In The Last Decade
Runfeng Li
44 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Pharmacology 326
- Complementary and alternative medicine 303
- Infectious Diseases 509
- Immunology 215
- Computational Theory and Mathematics 130
Countries citing papers authored by Runfeng Li
This map shows the geographic impact of Runfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runfeng Li more than expected).
Fields of papers citing papers by Runfeng Li
This network shows the impact of papers produced by Runfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runfeng Li. The network helps show where Runfeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Runfeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Hit paper breakdown → | 2020 | 495 |
| 2 | 2017 | 195 | |
| 3 | 2020 | 98 | |
| 4 | 2020 | 84 | |
| 5 | 2021 | 69 | |
| 6 | 2015 | 41 | |
| 7 | 2017 | 40 | |
| 8 | 2020 | 30 | |
| 9 | 2018 | 27 | |
| 10 | 2023 | 23 | |
| 11 | 2019 | 22 | |
| 12 | 2022 | 22 | |
| 13 | 2018 | 21 | |
| 14 | 2018 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2014 | 17 | |
| 17 | 2021 | 15 | |
| 18 | 2022 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 14 |
About Runfeng Li
Runfeng Li is a scholar working on Epidemiology, Immunology, Infectious Diseases, Molecular Biology and Complementary and alternative medicine, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (16 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Respiratory viral infections research (7 papers), Immune Response and Inflammation (6 papers), interferon and immune responses (6 papers), Computational Drug Discovery Methods (4 papers), COVID-19 Clinical Research Studies (4 papers) and Viral gastroenteritis research and epidemiology (4 papers). The work is most often cited by research in Pharmacology (326 citations), Complementary and alternative medicine (303 citations), Infectious Diseases (509 citations), Immunology (215 citations) and Computational Theory and Mathematics (130 citations). Runfeng Li has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Zifeng Yang, Haiming Jiang, Jin Zhao, Weiqi Pan, Qinhai Ma, Chufang Li, Yongxia Shi, Kui Zheng, Jun Dai and Jicheng Huang. Their work appears in journals such as Journal of Ethnopharmacology, International Immunopharmacology, Pharmacological Research, Phytomedicine and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.